TBEV-infected neuroblastoma cells (UKF-NB-4) were treated with the ABCG1 inhibitor32 benzamil at concentrations of 0, 6.25, and 12.5 μM, both 24 h prior to infection (pre-treated) and simultaneously with TBEV infection (N = 3). Here, ABCG1 is linked to infection.